The burgeoning role of global health diplomacy to alleviate suffering of cancer patients in low- and middle-income countries.


Journal

International health
ISSN: 1876-3405
Titre abrégé: Int Health
Pays: England
ID NLM: 101517095

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 11 11 2019
revised: 05 01 2020
accepted: 08 01 2020
pubmed: 7 3 2020
medline: 25 11 2020
entrez: 6 3 2020
Statut: ppublish

Résumé

The science of global health diplomacy (GHD) consists of cross-disciplinary, multistakeholder credentials comprised of national security, public health, international affairs, management, law, economics and trade policy. GHD is well placed to bring about better and improved multilateral stakeholder leverage and outcomes in the prevention and control of cancer. It is important to create an evidence base that provides clear and specific guidance for health practitioners in low- and middle-income countries (LMICs) through involvement of all stakeholders. GHD can assist LMICs to negotiate across multilateral stakeholders to integrate prevention, treatment and palliative care of cancer into their commercial and trade policies.

Identifiants

pubmed: 32134455
pii: 5781831
doi: 10.1093/inthealth/ihaa004
pmc: PMC7320424
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

231-233

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Références

JAMA Surg. 2019 Jun 1;154(6):475-476
pubmed: 30892582
JAMA Surg. 2018 May 1;153(5):497-498
pubmed: 29466537
World J Surg. 2018 Nov;42(11):3482-3492
pubmed: 29700566
Lancet. 2015 Jul 18;386(9990):e1
pubmed: 26183412
Lancet. 2016 May 21;387(10033):2133-2144
pubmed: 26578033
Bull World Health Organ. 2007 Mar;85(3):230-2
pubmed: 17486216
J Clin Oncol. 2016 Jan 1;34(1):53-61
pubmed: 26578620
Global Health. 2018 Jan 11;14(1):2
pubmed: 29325574
J Am Coll Surg. 2017 May;224(5):988-993
pubmed: 28167227
Lancet. 2019 Nov 16;394(10211):1780
pubmed: 31733927
World J Surg. 2019 Nov;43(11):2658-2665
pubmed: 31363826
ESMO Open. 2018 Feb 2;3(2):e000285
pubmed: 29464109

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH